FDA Drugs (New Approvals & NDA)Original article
CDER Nitrosamine Impurity Acceptable Intake Limits
RegulatoryNeutral
AI Analysis
Summary
The FDA CDER issued updated guidance on acceptable intake limits for nitrosamine drug substance-related impurities (NDSRIs). This is a routine regulatory guidance update applicable to pharmaceutical manufacturers.
Outcome Details
Updated guidance on acceptable intake limits for nitrosamine drug substance-related impurities (NDSRIs)
Importance:3/10
Sentiment:
0.00
FDACDERRegulatory GuidanceNitrosamine ImpuritiesDrug Safety
Read the original article
Published by FDA Drugs (New Approvals & NDA) on September 24, 2026 8:26 PM